Financial Highlights for the Nine Months Ended December 31, 2016 Contrast to the Nine Months Ended December 31, 2015 (unaudited):
- Net revenue of $42.7 million, a boost of 32% as contrast to $32.2 million in the comparable period of 2015.
- Loss from operations of $5.6 million as contrast to $3.5 million loss in the comparable period of 2015.
“We are happy with our continued year-over-year and quarter-over-quarter revenue growth, as we lay the foundation for future growth,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. “The planned investments we have made in our population health administration infrastructure continue to provide unique opportunities for the Company and our shareholders. We believe these investments will be further improved by the merger between ApolloMed and Network Medical Administration, which is expected to be accomplished in the first half of this year.”
“We believe the Company is well positioned for the accelerated transition in the U.S. healthcare system from fee-for-service to value-based reimbursements,” stated Gary Augusta, Executive Chairman of Apollo Medical Holdings. “We are also happy with our improved balance sheet, counting our positive total stockholder’s equity of $5.7 million.”